Cite

    Mikhailova, E., Roumiantseva, J., Illarionova, O., Lagoyko, S., Miakova, N., Zerkalenkova, E., Zharikova, L., Olshanskaya, Y., Novichkova, G., Maschan, M., Henze, G., Karachunskiy, A., & Popov, A. (2022). strong expansion of normal CD19‐negative B‐cell precursors after the use of blinatumomab in the first‐line therapy of acute lymphoblastic leukaemia in children. British journal of haematology, 196, e6–e9. http://access.bl.uk/ark:/81055/vdc_100148208435.0x00005f